🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial studies the side effects and best dose of FT-2102 wh...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-08-27
Trial ID
NCT04013880
Treatments Being Tested
This Phase 1/2 study will evaluate the safety, efficacy, PK, and PD of FT-2...
Status
Completed
Location
UCLA Medical Center
Start Date
2016-04-30
Trial ID
NCT02719574
Treatments Being Tested
This phase II MyeloMATCH treatment substudy tests the addition of olutaside...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-27
Trial ID
NCT07153497
This phase I trial tests the safety, side effects, and effectiveness of olu...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-01-17
Trial ID
NCT06543381
Treatments Being Tested
This phase II trial studies how well giving olutasidenib with azacitidine, ...
Status
Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2025-12-17
Trial ID
NCT07304011
Treatments Being Tested
This is an open-label, multi-center Phase 1 study of LY3410738, an oral, co...
Status
Active Not Recruiting
Location
City of Hope National Medical Center
Start Date
2020-11-19
Trial ID
NCT04603001
Treatments Being Tested
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-06-18
Trial ID
NCT05564390
Treatments Being Tested